GAAP Financial Statements
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
3 quarters · 1 annual periods · CIK 0001137883
Quarterly (3)
| Period | Form | Revenue | Gross Profit | Op. Income | Net Income | EPS (Basic) | EPS (Dil.) | Assets | Cash |
|---|---|---|---|---|---|---|---|---|---|
| Q3 FY2025 | 10-Q | — | — | -$2.0M | -$2.1M | $-0.19 | $-0.19 | $1.4M | $5.0K |
| Q2 FY2025 | 10-Q | — | — | -$2.6M | -$2.9M | $-0.34 | $-0.34 | $2.6M | $824.0K |
| Q1 FY2025 | 10-Q | — | — | -$3.1M | -$2.9M | $-0.45 | $-0.45 | $3.6M | $1.6M |
Annual (1)
| Period | Form | Revenue | Gross Profit | Op. Income | Net Income | EPS (Basic) | EPS (Dil.) | Assets | Cash |
|---|---|---|---|---|---|---|---|---|---|
| FY FY2024 | 10-K | — | — | -$11.7M | $11.6M | $-2.31 | $-2.31 | $1.8M | $187.0K |
Source: SEC EDGAR XBRL filings. Per-period figures are pulled from the original 10-Q / 10-K / 20-F submissions. Balance-sheet items (Assets, Cash, Equity) are point-in-time at period end.